Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple therapy of telmisartan + amlodipine + rosuvastatin in patients with dyslipidemia and hypertension
KCT0004273Phase 4Completed
- Sponsor
- Samjin Pharmaceutical Co., Ltd.
- Start
- Apr 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of telmisartan, amlodipine, rosuvastatin in hypertension (HTN), dyslipidemia, sponsored by Samjin Pharmaceutical Co., Ltd.. Started Apr 2019; status: completed.
02
Drugs
telmisartanamlodipinerosuvastatin
03
Conditions
hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on KCT0004273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004273.